Catalin Gabriel Herghelegiu

Dr. Catalin Gabriel Herghelegiu

Institutul National pentru Sanatatea Mamei si Copilului "Alessandrescu-Rusescu", Bucharest, Bucureşti, Romania
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2020 in Experimental and Therapeutic Medicine
Verified
Journal Article
Closed access
PDF file
ANAdrian Neacsu
Adrian Neacsu
Catalin Gabriel HerghelegiuCatalin Gabriel Herghelegiu
Catalin Gabriel Herghelegiu
SVSilviu Voinea
Silviu Voinea
MDMihai Cornel Traian Dimitriu
Mihai Cornel Traian Dimitriu
LPLiana Ples
Liana Ples
RIRaluca Gabriela Ioan
Raluca Gabriela Ioan
Despite advances in fetal monitoring during labor, one of the most critical causes of neonatal death and neurologic injuries remains intrapartum asphyxia. Umbilical cord gases can be used to detect acidosis and fetal distress. We conducted a retrospective, multicenter study to evaluate umbilical cord blood pH and lactate as a mean of evaluating the degree of intrapartum hypoxia and also to establish which of the two is more reliable in predicting morbidity in term neonates. The present study utilized a total of 124 cases that met the criteria for intrapartum asphyxia and 150 normal term newborns that were randomly selected as case control. Both umbilical cord lactate and pH proved to be accurate predictors of neonatal morbidity caused by intrapartum hypoxia. Lactate proved to be superior to pH in predicting adverse neonatal outcome. The greatest sensibility and specificity in predicting intrapartum asphyxia were achieved in our study by using a cutoff value of 3.75 mmol/l for lactate and 7.24 for pH.

1 July 2017 in Medicine
Verified
Journal Article
Open access
DHDoru Herghelegiu
Doru Herghelegiu
CICringu Ionescu
Cringu Ionescu
IPIrina Pacu
Irina Pacu
RBRoxana Bohiltea
Roxana Bohiltea
Catalin Gabriel HerghelegiuCatalin Gabriel Herghelegiu
Catalin Gabriel Herghelegiu
SVSimona Vladareanu
Simona Vladareanu
Vein of Galen aneurysmal malformation (VGAM) is a rare complex malformation of the cerebral vascular system consisting of arteriovenous shunts between the vein of Galen and the cerebral arteries. We present the case of a 31-year-old pregnant woman, para 1, gravida 1. At 26 weeks’ gestation who was examined for an anechoic mass on the cerebral median midline with color and pulsed Doppler. She presented with positive flow on the color and pulsed Doppler test, associated with hydrocephalus, cortical hypoplasia, cardiomegaly, jugular vein distension. No intervention for VGAM was done. This case of a VGAM was associated with negative prognostic factors. The ultrasound color Doppler together with the 3D power Doppler allowed reconstruction of the vascular connections and of the relationship of these with other anatomical structures, which contributed to establishing the prognosis.

16 June 2023 in Cells
Verified
Journal Article
Open access
PDF file
Catalin Gabriel HerghelegiuCatalin Gabriel Herghelegiu
Catalin Gabriel Herghelegiu
AVAlina Veduta
Alina Veduta
MSMiruna Florina Stefan
Miruna Florina Stefan
SMStefania Lucia Magda
Stefania Lucia Magda
IIIULIANA IONASCU
IULIANA IONASCU
ACAlina Mihaela Calin
Alina Mihaela Calin
Human chorionic gonadotropin (hCG) is produced by the placenta and its roles have been studied for over a century, being the first known pregnancy-related protein. Although its main role is to stimulate the production of progesterone by corpus luteal cells, hCG does not represent just one biologically active molecule, but a group of at least five variants, produced by different cells and each with different functions. The hyperglycosylated variant of hCG (H-hCG) plays a key role in trophoblast invasion, placental development and fetal growth. During trophoblast invasion, H-hCG promotes extravillous cytotrophoblast cells to infiltrate the decidua, and also to colonize and remodel the spiral arteries in to low resistance, larger-diameter vessels. As fetal growth is heavily reliant on nutrient availability, impaired trophoblast invasion and remodeling of the uterine arteries, leads to a defective perfusion of the placenta and fetal growth restriction. Understanding the function of H-hCG in the evolution of the placenta might unveil new ways to manage and treat fetal growth restriction.

1 July 2018 in Medicine
Verified
Journal Article
Open access
CICringu Ionescu
Cringu Ionescu
DCDan Calin
Dan Calin
DNDan Navolan
Dan Navolan
AMAlexandra Matei
Alexandra Matei
MDMihai Cornel Traian Dimitriu
Mihai Cornel Traian Dimitriu
LPLiana Ples
Liana Ples
Rationale: Holoprosencephaly is a structural malformation of the brain that results from the complete or incomplete noncleavage of the forebrain of the embryo into 2 hemispheres. We report a severe case of alobar holoprosencephaly diagnosed at 38 weeks, associated with cebocephaly, microcephaly, and craniosynostosis. Patient concern: The main knowledge added by this case is the late ultrasound diagnosis and chromosomal analysis that revealed a very rare abnormality (45X/46, XX/47, XX) with mosaicism at chromosome 18. Diagnoses: Investigation of the mother revealed nothing remarkable from clinical point of view and on laboratory tests. Ultrasonography identified a fetal biometry appropriate for gestational age, except for the head biometry and abdominal circumference, that were appropriate for less than the fifth percentile. Microcephaly, a large midline monoventricle, absent midlinestructures, cleft lip, cebocephaly (hypotelorism, single-nostril nose), ethmocephaly (hypotelorism, interorbital proboscis) and craniosynostosis, were also present. Fetal magnetic resonance imaging of fetus revealed an absent midline structure, a central monoventricle, abnormal corpus calosum, and abnormal gyri. Interventions: A cesarean section at 38 weeks was indicated for fetal bradycardia and a female baby was delivered, with Apgar score 6, weight 2290g. After birth, the diagnosis of the fetus confirmed holoprosencephaly with facial anomalies and demonstrated repeated tonic-clonic seizure, severe respiratory failure, cyanosis, decreased muscle tone, palor, and apnea. Laboratory examination of the newborn revealed acidosis and a prolonged of prothrombin time. The neonate was treated for severe respiratory distress syndrome, with immediate intubation and resuscitation. Vitamin K, fresh frozen plasma, and antibiotics were also administered. Outcomes: After delivery, exitus of the fetus occurred at 3 days and 18hours due to massive pulmonary hemorrhage. Lessons: We described a case of alobar holoprosencephaly diagnosed at 38 weeks of gestation and associated with a rare chromosomal abnormality (45X/46, XX/47, XX) with mosaicism at chromosome 18. Emotional implications could have been less severe if the patient underwent regular ultrasonography allowing a diagnosis in the first or early second trimester.

Verified
Journal Article
Open access
PDF file
Catalin Gabriel HerghelegiuCatalin Gabriel Herghelegiu
Catalin Gabriel Herghelegiu
Ana-Maria ZagreanAna-Maria Zagrean
Ana-Maria Zagrean
SDSimona Duta
Simona Duta
AVAna Maria Vayna
Ana Maria Vayna
Anca Marina CiobanuAnca Marina Ciobanu
Anca Marina Ciobanu
AVAlina Veduta
Alina Veduta
Congenital heart disease (CHD) is the most common birth defect, with a reported prevalence of 5–12 per 1000 live births. Very recently, the American Institute of Ultrasound in Medicine published a guideline recommending the use of the four-chamber and the three-vessel and trachea views to screen for CHD in the first trimester of pregnancy. Our aim is to present abnormal image patterns that are seen in the four-chamber, three-vessel, and trachea views of the fetal heart in the first trimester and to describe their association with specific CHD types. We used a total of 29 cases of CHD from the archives of Filantropia Hospital and the Maternal and Child Health Institute (INSMC) fetal medicine units. We selected cases with a clear and well-documented diagnosis of the CHD type. We identified a series of repeating color doppler flow patterns seen in the four-chamber, three-vessel, and trachea views of the studied cases. Our observations could be developed into a diagnosis algorithm to orientate the examiner to the most likely type of CHD in individual cases.

27 July 2023 in Life
Verified
Journal Article
Open access
PDF file
MSMiruna Florina Stefan
Miruna Florina Stefan
Catalin Gabriel HerghelegiuCatalin Gabriel Herghelegiu
Catalin Gabriel Herghelegiu
SMStefania Lucia Magda
Stefania Lucia Magda
The number of patients diagnosed with breast cancer and cardiovascular disease is continuously rising. Treatment options for breast cancer have greatly evolved, but radiotherapy (RT) still has a key role in it. Despite many advances in RT techniques, cardiotoxicity is one of the most important side effects. The new cardio-oncology guidelines recommend a baseline evaluation, risk stratification and follow-up of these patients. Cardiotoxicity induced by RT can be represented by almost all forms of cardiovascular disease, with atherosclerosis being the most frequent. An interdisciplinary team should manage these patients, in order to have maximum therapeutic effect and minimum cardiovascular toxicity. This review will summarize the current incidence, risk factors, mechanisms and follow-up of RT-induced cardiovascular toxicity.